SCHEMBL6924193

SCHEMBL6924193

COc1c(CN)cccc1-c1cc2ccccc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
MAPT P10636 4/20 0.57
RAB9A P51151 4/20 0.57
MEN1 O00255 3/20 0.57
ALDH1A1 P00352 3/20 0.57
HPGD P15428 3/20 0.57
KMT2A Q03164 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
F2 P00734 1/20 0.47
F10 P00742 1/20 0.47
PLG P00747 1/20 0.47
PLAU P00749 1/20 0.47
PLAT P00750 1/20 0.47
PRSS1 P07477 1/20 0.47
NPC1 O15118 3/20 0.47
CASP3 P42574 2/20 0.47
SENP8 Q96LD8 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
SENP6 Q9GZR1 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28283441 0.82 LOXL2 (0.53) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL27491417 0.73 FFAR1 (0.59) KDM4EMAPTRAB9AMEN1ALDH1A1
2-(2'-Methoxyphenyl)-1H-Indole SCHEMBL5634916 0.73 KDM4E (1.00) KDM4EMAPTRAB9AMEN1ALDH1A1
2-(2'-Methoxyphenyl)-1H-Indole SCHEMBL31053096 0.73 KDM4E (1.00) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL6503170 0.73 RAB9A (0.57) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL5051826 0.72 KDR (0.68) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL16428829 0.71 DPP4 (0.60) RAB9AF2F10PLGPLAU
SCHEMBL21484073 0.70 RAB9A (0.47) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL10176240 0.70 KDR (0.61) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL8732516 0.70 KDR (0.53) KDM4EMAPTRAB9AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors CONNOR DAVID THOMAS (US) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors ALOX15, ALOX5, ALOX12 KDM4E 881/4885MAPT 4865/4885RAB9A 4162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.